Page 4 - 09769810 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday, Zacks.com reports. According to Zacks, “Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company’s principal product […]

Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. The brokerage presently has a $1.75 price objective on the stock. Zacks Investment Research‘s price target would suggest a potential upside of […]

Zacks Investment Research cut shares of Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) from a buy rating to a hold rating in a research note published on Friday, Zacks.com reports. According to Zacks, “Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company’s principal product […]

Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) issued its quarterly earnings data on Wednesday. The company reported ($0.73) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.81) by $0.08, MarketWatch Earnings reports. Shares of NASDAQ BOLT traded down $0.06 during midday trading on Thursday, hitting $2.70. The company’s stock had a […]